4/23
11:08 am
halo
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Low
Report
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
4/23
08:47 am
halo
Halozyme to Report First Quarter 2024 Financial and Operating Results [Yahoo! Finance]
Low
Report
Halozyme to Report First Quarter 2024 Financial and Operating Results [Yahoo! Finance]
4/23
08:30 am
halo
Halozyme to Report First Quarter 2024 Financial and Operating Results
Low
Report
Halozyme to Report First Quarter 2024 Financial and Operating Results
4/18
01:52 pm
halo
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
Low
Report
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
4/16
10:13 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $50.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $50.00 price target on the stock.
4/16
01:04 am
halo
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease [Yahoo! Finance]
Low
Report
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease [Yahoo! Finance]
4/10
07:00 am
halo
Halozyme's Strategic Partnerships Fueling Next-Gen Therapeutics [Seeking Alpha]
Low
Report
Halozyme's Strategic Partnerships Fueling Next-Gen Therapeutics [Seeking Alpha]
4/4
07:28 am
halo
Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist? [Yahoo! Finance]
Medium
Report
Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist? [Yahoo! Finance]
3/28
01:18 pm
halo
Xeris gains as Oppenheimer highlights drug technology [Seeking Alpha]
Low
Report
Xeris gains as Oppenheimer highlights drug technology [Seeking Alpha]
3/21
01:38 pm
halo
Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report? [Yahoo! Finance]
3/20
11:23 am
halo
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Low
Report
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
3/12
02:28 am
halo
Should You Hold Halozyme Therapeutics (HALO)? [Yahoo! Finance]
Low
Report
Should You Hold Halozyme Therapeutics (HALO)? [Yahoo! Finance]
3/7
04:09 pm
halo
argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]
Low
Report
argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]
2/29
07:05 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) is now covered by analysts at TD Cowen. They set an "outperform" rating and a $54.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) is now covered by analysts at TD Cowen. They set an "outperform" rating and a $54.00 price target on the stock.
2/29
03:25 am
halo
Insider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ... [Yahoo! Finance]
Low
Report
Insider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ... [Yahoo! Finance]
2/27
08:43 am
halo
Halozyme to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Halozyme to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/27
08:30 am
halo
Halozyme to Participate in Upcoming Investor Conferences
Low
Report
Halozyme to Participate in Upcoming Investor Conferences
2/23
06:12 am
halo
Analyst Estimates: Here's What Brokers Think Of Halozyme Therapeutics, Inc. (NASDAQ:HALO) After Its Full-Year Report [Yahoo! Finance]
Medium
Report
Analyst Estimates: Here's What Brokers Think Of Halozyme Therapeutics, Inc. (NASDAQ:HALO) After Its Full-Year Report [Yahoo! Finance]
2/23
02:13 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/22
06:10 am
halo
Halozyme Therapeutics Full Year 2023 Earnings: EPS Beats Expectations [Yahoo! Finance]
Medium
Report
Halozyme Therapeutics Full Year 2023 Earnings: EPS Beats Expectations [Yahoo! Finance]
2/21
01:41 pm
halo
Halozyme (HALO) Q4 Earnings Match Estimates, Revenues Lag [Yahoo! Finance]
Low
Report
Halozyme (HALO) Q4 Earnings Match Estimates, Revenues Lag [Yahoo! Finance]
2/21
12:19 pm
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $72.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $72.00 price target on the stock.
2/21
09:10 am
halo
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/21
08:00 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at HC Wainwright from $48.00 to $50.00. They now have a "buy" rating on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at HC Wainwright from $48.00 to $50.00. They now have a "buy" rating on the stock.
2/20
07:13 pm
halo
Compared to Estimates, Halozyme Therapeutics (HALO) Q4 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, Halozyme Therapeutics (HALO) Q4 Earnings: A Look at Key Metrics [Yahoo! Finance]